NIH scientists outline steps toward Epstein-Barr virus vaccine

Vaccine could prevent mononucleosis and cancers linked to virus

2011-11-03

(Press-News.org) WHAT:
Epstein-Barr virus (EBV) infects nine out of ten people worldwide at some point during their lifetimes. Infections in early childhood often cause no disease symptoms, but people infected during adolescence or young adulthood may develop infectious mononucleosis, a disease characterized by swollen lymph nodes, fever and severe fatigue. EBV also is associated with several kinds of cancer, including Hodgkin lymphoma and stomach and nasal cancers. Organ transplant recipients and people infected with HIV (who become infected with or who already are infected with EBV) also may develop EBV-associated cancers. There is no vaccine to prevent EBV infection and no way for doctors to predict whether an EBV-infected person will develop virus-associated cancer.

In a new article from the National Institutes of Health (NIH), Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), and Harold Varmus, M.D., director of the National Cancer Institute (NCI), join Gary Nabel, M.D., Ph.D., director of NIAID's Vaccine Research Center, and Jeffrey Cohen, M.D., chief of NIAID's Laboratory of Infectious Diseases, in summarizing a recent meeting of experts who gathered to map directions toward an EBV vaccine. Although it may not be possible to create a vaccine that completely prevents EBV infection, the authors note, clinical observations and results from clinical trials of an experimental EBV vaccine suggest that it may be possible to create an EBV vaccine capable of preventing the diseases that sometimes follow EBV infection.

Priorities for future research include determining which immune system responses to vaccination correlate with protection from infection or disease; identifying biological markers that would enable clinicians to predict development of EBV-related cancers; and establishing collaborations among government, academic and industry scientists to further improve an experimental EBV vaccine and to spur development of second-generation EBV vaccines.

### ARTICLE:
JI Cohen et al. Epstein-Barr virus: An important vaccine target for cancer prevention. Science Translational Medicine DOI: 10.1126/scitranslmed.3002878 (2011).

WHO:
Scientific experts from NIAID and NCI are available to comment.

CONTACT:
To schedule interviews with Dr. Fauci or other NIAID authors, contact the NIAID Office of Communications, 301-402-1663, niaidnews@niaid.nih.gov.

To schedule interviews with NCI Director Dr. Harold Varmus, contact NCI press officers at 301-496-6641, ncipressofficers@mail.nih.gov.

NIAID conducts and supports research -- at NIH, throughout the United States, and worldwide -- to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

NCI leads the National Cancer Program and the NIH effort to dramatically reduce the burden of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers. For more information about cancer, please visit the NCI Web site at http://www.cancer.gov or call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.

ELSE PRESS RELEASES FROM THIS DATE:

NIH study examines nicotine as a gateway drug

2011-11-03

A landmark study in mice identifies a biological mechanism that could help explain how tobacco products could act as gateway drugs, increasing a person's future likelihood of abusing cocaine and perhaps other drugs as well, according to the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. The study is the first to show that nicotine might prime the brain to enhance the behavioral effects of cocaine. The gateway drug model is based upon epidemiological evidence that most illicit drug users report use of tobacco products or alcohol prior ...

Study shows promise for teen suicide prevention

2011-11-03

Roughly 1 million people die by suicide each year. In the U.S., where nearly 36,000 people take their own lives annually, more than 4,600 victims are between the ages of 10 and 24, making suicide the third leading cause of death in this age group. Youths treated at hospital emergency rooms for suicidal behavior remain at very high risk for future suicide attempts. But despite the urgent need to provide them with mental health follow-up care, many don't receive any such care after their discharge. Consequently, a major goal of the U.S. Department of Health and Human ...

Major breakthrough improves software reliability and security

2011-11-03

New York, NY -- Anyone who uses multithreaded computer programs -- and that's all of us, as these are the programs that power nearly all software applications including Office, Windows, MacOS, and Google Chrome Browser, and web services like Google Search, Microsoft Bing, and iCloud, -- knows well the frustration of computer crashes, bugs, and other aggravating problems. The most widely used method to harness the power we require from multicore processors, multithreaded programs can be difficult for programmers to get right and they often contain elusive bugs called races. ...

Astrobiologists discover 'sweet spots' for the formation of complex organic molecules in the galaxy

2011-11-03

Scientists within the New York Center for Astrobiology at Rensselaer Polytechnic Institute have compiled years of research to help locate areas in outer space that have extreme potential for complex organic molecule formation. The scientists searched for methanol, a key ingredient in the synthesis of organic molecules that could lead to life. Their results have implications for determining the origins of molecules that spark life in the cosmos. The findings will be published in the Nov. 20 edition of the Astrophysical Journal in a paper titled "Observational constraints ...

Evolution offers clues to leading cause of death during childbirth

2011-11-03

Unusual features of the human placenta may be the underlying cause of postpartum hemorrhage, the leading cause of maternal deaths during childbirth, according to evolutionary research at the University of Illinois at Chicago. Defined as the loss of more than a pint of blood during or just after vaginal delivery, postpartum hemorrhage accounts for nearly 35 percent, or 125,000, of the 358,000 worldwide annual maternal deaths during childbirth. Despite its prevalence, the causes of postpartum hemorrhage are unknown, says Julienne Rutherford, assistant professor of oral ...

Current training programs may not prepare firefighters to combat stress

2011-11-03

Current training programs may not effectively prepare firefighters for the range of scenarios they are likely to encounter, according to human factors/ergonomics researchers Michael R. Baumann, Carol L. Gohm, and Bryan L. Bonner. In their October 2011 Human Factors article, "Phased Training for High-Reliability Occupations: Live-Fire Exercises for Civilian Firefighters," the authors assess the value of current scenario-based training programs. Firefighters must make complex decisions and predictions and must perform extreme tasks at a moment's notice. Failure to keep ...

MU studies link depression and breast cancer outcomes

2011-11-03

COLUMBIA, Mo. – This year, more than 230,000 women will be diagnosed with breast cancer and nearly 40,000 women will not survive their battle with cancer, according to the American Cancer Society. New research from the University of Missouri shows that certain factors, including marital status, having children in the home, income level and age, affect the likelihood of depression in breast cancer survivors. Further, depressed patients are less likely to adhere to medication regimens, potentially complicating the progress of their treatment. Ann Bettencourt, professor ...

Watching the birth of an iceberg

2011-11-03

PUNTA ARENAS, CHILE – After discovering an emerging crack that cuts across the floating ice shelf of Pine Island Glacier in Antarctica, NASA's Operation IceBridge has flown a follow-up mission and made the first-ever detailed airborne measurements of a major iceberg calving in progress. NASA's Operation Ice Bridge, the largest airborne survey of Earth's polar ice ever flown, is in the midst of its third field campaign from Punta Arenas, Chile. The six-year mission will yield an unprecedented three-dimensional view of Arctic and Antarctic ice sheets, ice shelves and sea ...

Study shows new medication effectively treats underlying cause of cystic fibrosis

2011-11-03

SEATTLE -- A new study has confirmed that the drug, ivacaftor (VX-770), significantly improves lung function in some people with cystic fibrosis (CF). The results of the phase III clinical trial study, "A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation," led by Bonnie W. Ramsey, MD of Seattle Children's Research Institute and the University of Washington, were published today in the New England Journal of Medicine. Ivacaftor, also known as VX-770, was developed by Vertex Pharmaceuticals with financial support from the Cystic Fibrosis Foundation. ...

Scientists prevent cerebral palsy-like brain damage in mice

2011-11-03

Scientists at Washington University School of Medicine in St. Louis have shown that a protein may help prevent the kind of brain damage that occurs in babies with cerebral palsy. Using a mouse model that mimics the devastating condition in newborns, the researchers found that high levels of the protective protein, Nmnat1, substantially reduce damage that develops when the brain is deprived of oxygen and blood flow. The finding offers a potential new strategy for treating cerebral palsy as well as strokes, and perhaps Alzheimer's, Parkinson's and other neurodegenerative ...

NIH scientists outline steps toward Epstein-Barr virus vaccine

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: